Data from Phase 3 trials show vaccine offers 78 percent protection against COVID-19, says a study published in Lancet.
Source: Covaxin, India’s homegrown COVID jab, ‘highly efficacious’: Study
Doesn’t require diffficult to maintain cold storage, so good for everywhere. Not quite as effective against the .delta variant, but still very good..
